Variant report
Variant | nsv1028399 |
---|---|
Chromosome Location | chr6:66389079-66403840 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564846897 | chr6:66390837-66390838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2130491 | chr6:66390851-66390852 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs6927185 | chr6:66390862-66390863 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs140859453 | chr6:66390863-66390864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549752009 | chr6:66390924-66390925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142330756 | chr6:66390934-66390935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538786688 | chr6:66390936-66390937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs9453362 | chr6:66390941-66390942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558651269 | chr6:66390946-66390947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150832893 | chr6:66390949-66390950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs139239604 | chr6:66390955-66390956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539874427 | chr6:66390956-66390957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188410262 | chr6:66390959-66390960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575069535 | chr6:66390962-66390963 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115614708 | chr6:66390981-66390982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563757590 | chr6:66391058-66391059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs77973577 | chr6:66391090-66391091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149962085 | chr6:66391121-66391122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564981913 | chr6:66391137-66391138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527238574 | chr6:66391141-66391142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141011082 | chr6:66391152-66391153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373919073 | chr6:66391177-66391178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143424996 | chr6:66391189-66391190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs529980912 | chr6:66391199-66391200 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs192139667 | chr6:66391203-66391204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs573747990 | chr6:66391259-66391260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146722183 | chr6:66391270-66391271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs538845319 | chr6:66391275-66391276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs2087538 | chr6:66391281-66391282 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs148859245 | chr6:66391282-66391283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183460922 | chr6:66391296-66391297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544446008 | chr6:66391299-66391300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs143486479 | chr6:66391332-66391333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575053922 | chr6:66391370-66391371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537316529 | chr6:66391402-66391403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187995093 | chr6:66391403-66391404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs577325283 | chr6:66391405-66391406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs147987041 | chr6:66391411-66391412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558683295 | chr6:66391418-66391419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572212728 | chr6:66391445-66391446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs373638829 | chr6:66391448-66391449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541012702 | chr6:66391510-66391511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562633794 | chr6:66391552-66391553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529716890 | chr6:66391606-66391607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543320985 | chr6:66391645-66391646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs59121619 | chr6:66391650-66391651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs563612379 | chr6:66391674-66391675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9342494 | chr6:66391675-66391676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs551990516 | chr6:66391708-66391709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs565817618 | chr6:66391711-66391712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Ovarian cancer | 19835627 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Retinitis pigmentosa | 21519034 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:66390800-66391000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr6:66390800-66391200 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr6:66390800-66391800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:66391400-66392000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr6:66392800-66393800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr6:66393800-66396000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr6:66396000-66396200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:66396200-66396600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr6:66399600-66400400 | Enhancers | Placenta | Placenta |
10 | chr6:66401800-66402200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
11 | chr6:66402200-66403400 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
12 | chr6:66403600-66403800 | Enhancers | Rectal Mucosa Donor 29 | rectum |